Reuters logo
BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clozapine Tablets
December 8, 2017 / 5:36 AM / 3 days ago

BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clozapine Tablets

Dec 8 (Reuters) - Cadila Healthcare Ltd:

* SAYS ZYDUS GET FINAL NOD FROM U.S. FDA FOR CLOZAPINE TABLETS USP

* DRUG USED TO TREAT SCHIZOPHRENIA ; DRUG TO BE MANUFACTURED AT GROUP'S FORMULATIONS MANUFACTURING FACILITY AT AHMEDABAD Source text - bit.ly/2AE95qi Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below